Docosyl ferulate manufacturers
- Docosylferulate
-
- $1028.00
-
2026-07-27
- CAS:101927-24-6
- Purity:
- Supply Ability: 10g
|
| | Docosyl ferulate Basic information |
| Product Name: | Docosyl ferulate | | Synonyms: | DOCOSYL FERULATE (50 MG)F0E1430.99MG/MG(AI);Docosyl Ferulate (50 mg);1-Docosyl ferulate;E-Ferulic acid docosyl ester;2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, docosyl ester, (2E)-;(E)-Docosyl 3-(4-hydroxy-3-methoxyphenyl)acrylate;Docosyl Ferulate;Docosyl trans-ferulate | | CAS: | 101927-24-6 | | MF: | C32H54O4 | | MW: | 502.77 | | EINECS: | | | Product Categories: | | | Mol File: | 101927-24-6.mol |  |
| | Docosyl ferulate Chemical Properties |
| Boiling point | 596.552±35.00 °C(Press: 760.00 Torr)(predicted) | | density | 0.968±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | solubility | Chloroform (Slightly), Methanol (Slightly, Heated, Sonicated) | | form | Solid | | pka | 9.752±0.31(predicted) | | color | White to Off-White | | Stability: | Light Sensitive | | Major Application | pharmaceutical (small molecule) | | InChI | 1S/C32H54O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-27-36-32(34)26-24-29-23-25-30(33)31(28-29)35-2/h23-26,28,33H,3-22,27H2,1-2H3 | | InChIKey | USNYNNITUQSEEV-UHFFFAOYSA-N | | SMILES | O(C)c1c(ccc(c1)C=CC(=O)OCCCCCCCCCCCCCCCCCCCCCC)O |
| WGK Germany | WGK 3 | | HS Code | 2918992090 | | Storage Class | 11 - Combustible Solids |
| | Docosyl ferulate Usage And Synthesis |
| Uses | Docosyl Ferulate is a compound derived form Ferulic Acid (F308900), widely distributed in small amounts in plants. Used as an antioxidant and food preservative. | | Definition | ChEBI: Docosyl trans-ferulate is a hydroxycinnamic acid. It has a role as a metabolite. | | Application | Docosyl ferulate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monograph such as:
Pygeum Capsules
Pygeum Extract | | Biological Activity | Docosyl ferulate is a protocatechuic acid analogue. It inhibits tyrosinase (an enzyme that catalyses the conversion of tyrosinase into melanin) and has anticancer activity in vitro. It inhibits the growth of cancer cells by binding to the receptor protein CXCR4 on the surface of tumour cells. The compound also inhibited angiotensin II-induced elevation of blood pressure in rats, probably due to its ability to inhibit tyrosine kinase activity. In addition, Docosyl ferulate has been shown to inhibit growth factor beta (GFβ) and cell proliferation in human skin cells. |
| | Docosyl ferulate Preparation Products And Raw materials |
|